Analyzing...
This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended June 30, 2024, is available on our website URL https://eris.co.in/financials/
(File name: Transcript of the Analyst and Investor Conference Call Q1FY25).
Thanking You,
For Eris Lifesciences Limited
_________________________ Milind Talegaonkar Company Secretary and Compliance Officer ICSI Mem. No. A26493 MILIND TALEGAONKAR